UCLA Hematology/Oncology- Santa Barbara — Santa Barbara, California

UCLA Hematology/Oncology- Santa Barbara is a clinical research site located in Santa Barbara, California, United States 93101.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

UCLA Hematology/Oncology- Santa Barbara has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer.

Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Santa Barbara

Browse all research sites in California · View every site in Santa Barbara

• Santa Barbara Cottage Children's Hospital
• Cottage Hospital
• University of California, Santa Barbara, School of Education, Department of Clinical, Counseling, and School Psychology
• Goleta Valley Cottage Hospital
• Sutter Valley Hospitals Santa Barbara
• Cottage Health | Santa Barbara Cottage Hospital - Cardiology Department
• Santa Barbara Cottage Hospital Research Institute
• University of California Santa Barbara
• Santa Barbara Cottage Hospital
• Cottage Health | Santa Barbara Cottage Hospital - Research Department
• Santa Barbara Cottage Hospital/Sansum Clinic
• Fielding Graduate University

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Hematology/Oncology- Santa Barbara?

UCLA Hematology/Oncology- Santa Barbara has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Hematology/Oncology- Santa Barbara conducted?

UCLA Hematology/Oncology- Santa Barbara has 5 clinical trials on record, with 3 currently active. Their work covers Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer.

Is UCLA Hematology/Oncology- Santa Barbara accredited by Crixeo Clinical Trials?

UCLA Hematology/Oncology- Santa Barbara has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Hematology/Oncology- Santa Barbara?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.